In-hospital mortality following pericardiocentesis is driven by effusion etiology and hemodynamic severity rather than comorbidity burden.
Cohort (n=62)
No
Does effusion etiology and hemodynamic severity predict in-hospital mortality in adults undergoing pericardiocentesis?
In-hospital mortality following pericardiocentesis is primarily determined by the underlying etiology and hemodynamic severity rather than the patient's general comorbidity burden.
p-value: p=0.27
AIMS: This study evaluated the impact of effusion etiology, hemodynamic presentation, and comorbidity burden on in-hospital outcomes following pericardiocentesis. PATIENTS AND METHODS: A retrospective analysis of 62 adults who underwent pericardiocentesis at a tertiary academic hospital (2021-2024) was performed. The primary outcome was in-hospital mortality. The Charlson Comorbidity Index (CCI) and a post hoc Pericardial Risk Score (PRS) were evaluated as predictors. RESULTS: = 0.27). CONCLUSIONS: Pericardiocentesis remains safe and effective with low recurrence. Mortality is driven by effusion etiology and hemodynamic severity rather than comorbidity burden. A simple etiology-physiology risk score outperformed the CCI and may help guide post-procedural management.
Sami et al. (Mon,) conducted a cohort in Pericardial effusion (n=62). Pericardiocentesis was evaluated on In-hospital mortality (p=0.27). In-hospital mortality following pericardiocentesis is driven by effusion etiology and hemodynamic severity rather than comorbidity burden.